Institutional Ownership Navidea Biopharmaceuticals, Inc. (NAVB)
This table provides information about the institutional ownership of Navidea Biopharmaceuticals, Inc. (NAVB). We have compiled data on the 2 institutions that hold shares in the stock, with a total of 10,048 shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Pathstone Family Office, LLC
Englewood, NJ |
Nov 08, 2023 Q3 2023 |
10,043
shares
|
$0
0.0% of portfolio
|
Q4 2022
Reduced 0.07%
|
|
|
Runnymede Capital Advisors, Inc.
Dublin, OH |
Feb 11, 2025 Q4 2024 |
5
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|